Trial Profile
Post-Marketing Surveillance Experience of Tofacitinib - 18-month Worldwide
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 May 2015
Price :
$35
*
At a glance
- Drugs Tofacitinib (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- 05 May 2015 New trial record